<?xml version="1.0" encoding="UTF-8"?>
<ref id="ref37">
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Le</surname>
    <given-names>RQ</given-names>
   </name>
   <name>
    <surname>Li</surname>
    <given-names>L</given-names>
   </name>
   <name>
    <surname>Yuan</surname>
    <given-names>W</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>FDA approval summary: tocilizumab for treatment of chimeric antigen receptor T cell induced severe or life threatening cytokine release syndrome</article-title>. 
  <source>The Oncologist</source>
  <year>2018</year>;
  <volume>23</volume>:
  <fpage>943</fpage>.
  <pub-id pub-id-type="pmid">29622697</pub-id>
 </mixed-citation>
</ref>
